Chemed Corp (NYSE:CHE) — Market Cap & Net Worth
Market Cap & Net Worth: Chemed Corp (CHE)
Chemed Corp (NYSE:CHE) has a market capitalization of $6.29 Billion ($6.29 Billion) as of September 21, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #3085 globally and #1087 in its home market, demonstrating a -2.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chemed Corp's stock price $504.06 by its total outstanding shares 14108915 (14.11 Million). Also see Chemed Corp asset portfolio for a full breakdown of the balance sheet.
Chemed Corp Market Cap History: 2015 to 2026
Chemed Corp's market capitalization history from 2015 to 2026. Data shows growth from $2.04 Billion to $7.11 Billion (13.32% CAGR). Also see Chemed Corp (CHE) cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Chemed Corp is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.43 Trillion | 0.35% | #218 of 401 |
Weight: Chemed Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Chemed Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chemed Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Chemed Corp share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.07x
Chemed Corp's market cap is 3.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
24.75x
Chemed Corp's market cap is 24.75 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.04 Billion | $1.54 Billion | $110.27 Million | 1.32x | 18.51x |
| 2016 | $2.20 Billion | $1.58 Billion | $108.74 Million | 1.40x | 20.25x |
| 2017 | $3.35 Billion | $1.67 Billion | $98.18 Million | 2.01x | 34.16x |
| 2018 | $3.92 Billion | $1.78 Billion | $205.54 Million | 2.20x | 19.09x |
| 2019 | $6.11 Billion | $1.94 Billion | $219.92 Million | 3.15x | 27.76x |
| 2020 | $7.42 Billion | $2.08 Billion | $319.47 Million | 3.57x | 23.24x |
| 2021 | $7.40 Billion | $2.14 Billion | $268.55 Million | 3.46x | 27.54x |
| 2022 | $7.16 Billion | $2.13 Billion | $249.62 Million | 3.35x | 28.67x |
| 2023 | $8.22 Billion | $2.26 Billion | $272.51 Million | 3.63x | 30.18x |
| 2024 | $7.47 Billion | $2.43 Billion | $302.00 Million | 3.07x | 24.75x |
Competitor Companies of CHE by Market Capitalization
Companies near Chemed Corp in the global market cap rankings as of September 21, 2026. Review CHE tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Chemed Corp by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #291 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #916 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #996 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1233 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #291 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $427.71 |
| #916 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €45.92 |
| #996 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1233 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $261.99 |
Chemed Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Chemed Corp's market cap moved from $2.04 Billion to $ 7.11 Billion, with a yearly change of 13.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.11 Billion | +17.81% |
| 2025 | $6.04 Billion | -19.24% |
| 2024 | $7.47 Billion | -9.11% |
| 2023 | $8.22 Billion | +14.90% |
| 2022 | $7.16 Billion | -3.22% |
| 2021 | $7.40 Billion | -0.38% |
| 2020 | $7.42 Billion | +21.59% |
| 2019 | $6.11 Billion | +55.58% |
| 2018 | $3.92 Billion | +17.01% |
| 2017 | $3.35 Billion | +52.32% |
| 2016 | $2.20 Billion | +7.89% |
| 2015 | $2.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 21st, 2026 the market cap of Chemed Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.29 Billion USD |
| MoneyControl | $6.29 Billion USD |
| MarketWatch | $6.29 Billion USD |
| marketcap.company | $6.29 Billion USD |
| Reuters | $6.29 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commer… Read more